U.S. Pharma Stock News

AbbVie (NYSE:ABBV) has agreed to offer Humira at a major discount through the new government run TrumpRx platform in the U.S. The company and partner Roche are among the first large drugmakers to participate in TrumpRx, signaling a shift in how high cost therapies may be distributed and priced. Separately, AbbVie and Nxera Pharma have reached a third research milestone in their neurological drug discovery collaboration, triggering additional potential milestone and royalty...

Renewed attention on StandardAero (SARO) has been sparked by fresh commentary from Middle Coast Investing, just as the aircraft maintenance specialist prepares to present at the MRO Americas 2026 conference in Orlando on April 21. See our latest analysis for StandardAero. At a share price of $26.81, StandardAero has a 1 month share price return of 4.73% and a year to date share price return of 9.55%. The 1 year total shareholder return of 10.69% suggests longer term holders have fared better...

Why Paycom Software (PAYC) is on investors’ radar today Paycom Software (PAYC) shares have been moving in recent weeks, with the stock up about 6% over the past month and still showing a negative return over the past 3 months and year. See our latest analysis for Paycom Software. The recent 11.2% 7 day share price return contrasts with a 12.7% year to date share price decline and a 35.0% 1 year total shareholder return loss, suggesting momentum has picked up after a prolonged weak patch. If...

In the first quarter of 2026, Alcoa Corporation reported sales of US$3,193 million and net income of US$425 million, alongside higher aluminum production but lower bauxite volumes versus a year earlier. The company kept its 2026 alumina and aluminum production guidance unchanged, underscoring operational stability while analysts highlighted its high operating leverage amid strong aluminum pricing. Next, we’ll examine how Alcoa’s steady full-year production guidance and operational...

Independent Bank (INDB) is back in focus after first quarter results showed higher net interest income of US$212.46 million and net income of US$79.92 million, along with sharply lower net charge offs and increased capital returns. See our latest analysis for Independent Bank. At a share price of US$79.23, the stock has a 1 day share price return of 1.64% and a 30 day share price return of 6.06%, while the 1 year total shareholder return of 50.10% and 3 year total shareholder return of 52.79%...

Earlier this month, Coinbase Global, Inc. disclosed that director Paul Clement will not stand for re-election at the 2026 Annual Meeting, with the board planning to shrink from ten to nine members, and was also named in a New York lawsuit alleging it facilitated illegal online gambling involving a minor through cryptocurrency transactions. The combination of a board reshuffle and serious allegations around underage gambling exposure raises fresh questions about Coinbase’s governance,...

Steele Bancorp (OTCPK:STLE) has just posted Q1 2026 results with Q4 2025 numbers showing total revenue of US$13.5 million and basic EPS of US$1.64, capping off a trailing twelve month period where reported earnings grew 410.8%. Over the last year, total revenue has moved from US$4.59 million in Q4 2024 to US$13.5 million in Q4 2025, while trailing EPS climbed from US$2.41 to US$9.15, with much of that uplift tied to a one off US$12.8 million gain and a net profit margin that now sits at...

Autoliv (NYSE:ALV) is expanding beyond traditional car airbags into motorcycle and wearable airbag safety products. The company has introduced its first motorcycle airbag and wearable airbag solutions, targeting riders and other vulnerable road users. Autoliv has recently outperformed in Asian markets such as China, India, and South Korea alongside this product expansion. Autoliv, trading around $121.36, is increasingly tied to broader mobility safety rather than just passenger vehicles...

Thermo Fisher Scientific (TMO) has been in focus after launching the Applied Biosystems PowerFlex Thermal Cycler, a next generation PCR instrument, along with new collaborations in data driven clinical development and large scale proteomics research. See our latest analysis for Thermo Fisher Scientific. These product launches and collaborations come as Thermo Fisher’s share price shows mixed momentum, with a 10.88% 1 month share price return contrasted against a 15.02% 3 month share price...

If you are wondering whether BlackSky Technology at US$37.42 is richly priced or still has room to run, it helps to step back and look at the valuation through a few different lenses. The stock has seen sharp recent moves, with returns of 7.6% over 7 days, 43.4% over 30 days, 79.7% year to date, and very large gains over 12 months at 464.4%, set against a 3 year return of 246.5% and a 5 year return of 53.1% decline. Recent coverage has focused on BlackSky Technology's role as a listed...

Why Lodestar's New Identity Matters for Old Republic International (ORI) Old Republic International (ORI) is giving its third party administrator business a separate identity with the launch of Lodestar Claims & Risk Services as an independent brand and standalone operating company within the group. This move brings a clearer profile for a top 10 national TPA that already provides claims administration and risk services across all 50 states. It also opens up fresh questions about how this...

iQIYI (IQ) has drawn fresh investor attention after announcing iQIYI LAND Wuhan, its fourth theme park and first integrated into an urban renewal project, which extends its content into physical cultural tourism experiences. See our latest analysis for iQIYI. The new Wuhan project comes after a mixed stretch for the stock, with a 7 day share price return of 9.45% and 30 day share price return of 13.01%, but a 1 year total shareholder return of 15.76% and 5 year total shareholder return of...

If you are wondering whether Tutor Perini at around US$84 is still priced attractively after a strong run, you are not alone. That is exactly what this valuation focused review will unpack. The stock has posted returns of 0.7% over the last week, 21.7% over the last month, 21.7% year to date and 327.1% over the past year. This naturally raises questions about how much value is already reflected in the share price. Recent headlines around Tutor Perini have centered on the company winning and...

If you are wondering whether Nasdaq stock is attractively priced at today's level, you are not alone. The answer depends on how you think about value. The share price last closed at US$87.78, with returns of 1.9% over the past week, 1.7% over the past month, a 9.2% decline year to date, and 25.7% over 1 year, 61.8% over 3 years, and 76.1% over 5 years. Together, these figures hint at shifting expectations around both growth potential and risk. Recent news around Nasdaq has focused on its...

Why SmartStop Self Storage REIT is on investors’ radar SmartStop Self Storage REIT (SMA) has drawn attention after a period of recent share gains, with the stock up around 10% over the past month and about 3% in the past 3 months. At a recent closing price of $33.39 and a market value near $1.8b, SmartStop sits in the mid cap range for U.S. real estate, giving investors a sizeable but still focused exposure to the self storage segment. See our latest analysis for SmartStop Self Storage...

If you are wondering whether TransUnion at around US$77.75 is offering fair value or an opportunity, the next sections break down what the current market price might be implying. The stock has moved 8.1% over the past week and 10.2% over the last 30 days, while returns sit at 10.6% over 1 year, 23.8% over 3 years, and a 20.7% decline over 5 years. This gives a mixed picture for anyone thinking about long term entry points. Recent coverage of TransUnion has focused on how investors are...

ADMA Biologics (ADMA) is back in focus after recent analyst downgrades tied to allegations of Asceniv revenue channel stuffing, rising days' sales outstanding and accounts receivable, and criticism of the company’s public response. See our latest analysis for ADMA Biologics. The recent short report and analyst downgrades come after a difficult stretch for ADMA’s share price, with a 30 day share price return of a 24.02% decline and a year to date share price return of a 39.15% decline, even...

Why C.H. Robinson Worldwide is on investors’ radar today C.H. Robinson Worldwide (CHRW) has drawn attention after a period of solid recent returns, including roughly 12% year to date and about 10% over the past year. This performance has prompted closer scrutiny of its freight focused business. See our latest analysis for C.H. Robinson Worldwide. The recent move up to a share price of $183.95, supported by a 7 day share price return of 11.54% and a very large 1 year total shareholder return...

LGI Homes (LGIH) has opened its Desert Edge community in Tooele County, Utah, a 700-home development featuring upgraded amenities and opening weekend incentives, providing investors with an additional data point on the stock. See our latest analysis for LGI Homes. The share price has moved sharply in the short term, with a 1 day share price return of 5.95% and a 30 day share price return of 34.78%. However, the 1 year total shareholder return of 17.74% and 5 year total shareholder return of...

What AT&T’s Recent Returns Say About Investor Sentiment AT&T (T) has attracted fresh attention after a mixed run in recent months, with the share price down about 7.5% over the past month but up roughly 11.6% in the past 3 months. Over the past year, the stock shows a total return of about 3.8%, with year to date performance around 6.6%. These returns sit alongside annual revenue of roughly US$125.6b and net income of about US$21.9b. See our latest analysis for AT&T. Recent trading shows a...

If you are wondering whether Janus Henderson Group is still reasonably priced after its strong run, this breakdown will help you frame what the current share price could mean for value. The stock closed at US$51.53 recently, with returns of 2.2% over 30 days, 7.8% year to date, 79.4% over 1 year, 123.5% over 3 years and 90.6% over 5 years. This naturally raises questions about how much of the story is already reflected in the price. Recent coverage has focused on how Janus Henderson Group...

Alphabet, ticker NasdaqGS:GOOGL, is reportedly in advanced talks with Marvell Technology to co develop two custom AI processors. The new chips are expected to focus on AI inference efficiency and memory processing for Google Cloud AI workloads. This move would deepen Alphabet's control over its AI hardware stack and adjust its relationships with existing silicon partners. For investors tracking NasdaqGS:GOOGL, this potential partnership comes with the shares at around $337.42 and a 1 year...

Muncy Columbia Financial (OTCPK:CCFN) has put up another solid set of numbers, with Q4 2025 revenue at US$19.2 million, basic EPS of US$2.09, and net income of US$7.4 million heading into its Q1 2026 reporting period. Over recent quarters the bank has seen revenue move from US$15.5 million in Q4 2024 to US$19.2 million in Q4 2025, while quarterly EPS shifted from US$1.47 to US$2.09 over the same span, all feeding into trailing 12 month earnings growth of 27.3% and a net margin of 34.5%. Taken...

To understand what AdaptHealth might be worth to you as an investor, it helps to separate the share price story from the underlying value story. That is what this article sets out to do. Over the past year, the stock has recorded a 72.9% return, with returns of 2.8% over 7 days, 27.9% over 30 days, and 31.0% year to date, while the 3 year return is 4.5% and the 5 year return is a 57.0% decline, indicating a mixed longer term picture. Recent company developments and sector sentiment shifts...